Canine Cell Line Culturing and Immune Modulation
Corresponding Organization :
Other organizations : Hokkaido University, Hokkaido University Hospital, Tohoku University
Variable analysis
- Meloxicam (5 μM)
- Prostaglandin E2 (2.5 μM)
- Canine chimeric anti-PD-L1 antibody c4G12 (20 μg/mL)
- Cell growth/proliferation of canine melanoma cell lines (CMeC, LMeC, CMM-1, CMM-2)
- Cell growth/proliferation of canine osteosarcoma cell lines (POS, HMPOS)
- Immune response of canine PBMCs (Peripheral Blood Mononuclear Cells)
- RPMI 1640 medium supplemented with 10% FCS, 2 mM L-glutamine, 200 μg/mL streptomycin, and 200 U/mL penicillin
- Canine PBMCs stimulated with 5 μg/mL Staphylococcal Enterotoxin B (SEB) and 1 μg/mL anti-canine CD28 antibody
- Canine PBMCs stimulated with 5 μg/mL Staphylococcal Enterotoxin B (SEB) and 1 μg/mL anti-canine CD28 antibody
- Dog IgG
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!